Slide 1: First-half 2022 report
First-half 2022 report Webcast for investors, analysts and media Basel, August 16, 2022 1 Disclaimer This presentation contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause ac
Slide 2: Agenda
Agenda Highlights Guillaume Daniellot Business & regional review Peter Hackel Recent achievements & strategy in action Guillaume Daniellot Outlook 2022 Guillaume Daniellot Guillaume Daniellot Q&A and upcoming events Peter Hackel 3 Highlights Guillaume Daniellot, CEO 4 2
Slide 3: Strong growth continues in the second quarter
Strong growth continues in the second quarter SECOND QUARTER REVENUE ORGANIC GROWTH1 CORE PROFITABILITY CHF 589 million 15.1% EBIT margin 27.9% H1: CHF 1.178 billion H1: 20.8% IFRS EBIT margin 27.5% H1: 200bps currency headwind IMPLANTOLOGY ORTHODONTICS OUTLOOK2 Strong performance Acquiring PlusDent
Slide 4: Increasing uncertainties; company transformed from 2007 to today
Increasing uncertainties COVID-19 lockdowns Inflation 7 7 Company transformed from 2007 to today Global footprint Product mix Multi-pricing strategy Premium Challenger Western Europe Premium implant solutions Eco-Challenger Emerging markets (EM) Challenger implant solutions, Other developed countrie
Slide 5: More than CHF 1bn revenue in the first half of 2022
Business and regional review Peter Hackel, CFO 9 More than 1bn revenue in the first half of 2022 Revenue development (in CHF million, rounded) Regional share of 19.6% organic growth in CHF 20.8% organic Change in organic growth 26.8% 14.0% 11.8% 44.0% 10 10 5
Slide 6: EMEA remains biggest region; APAC impacted by lockdowns
EMEA remains biggest region and gains share EMEA Revenue change (organic) Germany, Turkey and Iberia 101.5% 56% drive growth Premium and challenger implant sales high 45% of Group* 32.1% 25.8% 33.0% 27.0% 21.0% Digital remarkably successful 7.4% 5.9% DSO lifted revenue Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q
Slide 7: Double-digit growth across all businesses; core financials
Double-digit growth across all businesses Tooth replacement Digital Solutions Tooth alignment and restoration 13 13 Core financials at a glance % of Margin Change In CHF million, rounded H1 2022 Comments revenue change in % Revenue 1’178.3 19.6% COGS (282.6) 24.0%placeholder 20.8% GROSS PROFIT 895.7
Slide 8: Reported financials at a glance; core results reconciliation
Reported financials at a glance % of Margin Change In CHF million, rounded H1 2022 Comments revenue change in % Revenue 1’178.3 19.6% COGS (282.7) 24.0%placeholder 20.8% GROSS PROFIT 895.7 76.0% (30bps) 19.2% FX headwind -50bps Operating expenses (571.8) 48.7% 20.9% EBIT 323.9 27.5% (80bps) 16.3% FX
Slide 9: Core gross margin at 76%; core EBIT margin almost at 28%
Core Gross Margin at 76% In %, rounded -30bps 20bps 76.2 17 17 Core EBIT margin almost at 28% In %, rounded -90bps -30bps 18 18 9
Slide 10: Core net profit margin stable; free cash flow impacted
Core net profit margin remains stable In CHF million, rounded Of which CHF 49m earn-out adj. DrSmile Net profit Net profit margin margin 23.1% 22.8% 19 19 Free cash flow impacted by the net working capital In CHF million, rounded Operating cash flow In CHF million Y/Y change H1 2021 256.7 H1 2022 16
Slide 11: Recent achievements & strategy in action
Continuing to invest in our production sites Straumann manufacturing, Villeret & ClearCorrect & Neodent manufacturing, Curitiba, BR Corgément, CH Capacity / Capacity machines Capacity expansion expansion expansion Technology & Innovation Center, China Campus Shanghai, CN Arlesheim, CH Ground- Constr
Slide 12: Premium immediacy portfolio; challenger brands expanding
Premium immediacy portfolio performing at full speed Patient and clinician demand for short time to teeth and immediacy solutions remains strong Comprehensive Straumann portfolio of immediacy solutions increases addressable market as we are tapping into the edentulous segment Immediacy solutio
Slide 13: Accelerating digital transformation; Straumann AXS launched
Accelerate the digital transformation by reimagining the clinician and patient treatment journey Products, 1. Straumann AXS: Services & 2. Clinical Applications Solutions Practice Module Customer One centric core Data & Internal infrastructure Techno- Processes logy 3. Consumers & Patients Apps 25 2
Slide 14: ClearCorrect strengthened offering; PlusDental acquisition
ClearCorrect further strengthened its offering ClearPilot 4.0 software launch: including bite ramps feature to treat class II malocclusions Introduction of ClearCorrect Clinic App for patient communication First global orthodontics medical advisory 3D controls and 3D visualization Prescription
Slide 15: Net-zero by 2040; CFO Peter Hackel to leave
Group plans to achieve net-zero carbon emissions by 2040 29 29 Peter Hackel, CFO, decides to leave after 8 years of service Peter Hackel leaving Straumann Group by January 2023 Significant achievements over the past eight years Successfully supported the growth journey and tackled financial ch
Slide 16: Outlook 2022
Outlook 2022 31 Outlook 2022 confirmed Market Well positioned to anticipate and mitigate potential supply chain disruption, inflationary and geopolitical developments environment Group aims to achieve organic revenue growth in the low double- Our revenue digit percentage range versus the strong
Slide 17: Questions & answers; calendar of upcoming events
Questions & answers Q&A 33 Calendar of upcoming events 2022 Event Location 7 September J.P. Morgan CEO Call 2022 Virtual 8 September UBS Best of Switzerland Conference Wolfsberg, Switzerland 12 - 13 September BofA Roadshow North America Miami, New York 15 September BofA Global Health Conference Lond
Slide 18: Straumann Group's currency exposure
Straumann Group’s currency exposure Revenue breakdown H1 2022 Exchange rates development Jan 2021 - Jun 2022 CHF Other 1% 120.0000 19% EUR 31% BRL 110.0000 6% 100.0000 CNY 10% 90.0000 USD/CAD/AUD 12.2020 03.2021 06.2021 09.2021 12.2021 03.2022 06.2022 33% USDCHF EURCHF CNYCHF BRLCHF Total cost break